NCT00118313 2020-03-27
Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
University of Virginia
Phase 1 Completed
Clinical Trials
6 trialsNCT00003897 2019-11-19
Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
University of Wisconsin, Madison
Phase 1 Completed
NCT00568763 2018-10-31
Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma
Mayo Clinic
Phase 1 Completed
NCT00471471 2017-06-22
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
University of Pittsburgh
Phase 1 Completed
NCT00017121 2016-07-06
Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT00037037 2013-12-18
Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
National Cancer Institute (NCI)
Phase 1 Unknown